Giant cell hepatitis withautoimmune haemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapy may results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.

L'epatite gigantocellulare associata ad anemia emolitica autoimmune

NASTASIO, SILVIA;MAGGIORE, GIUSEPPE
2014

Abstract

Giant cell hepatitis withautoimmune haemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapy may results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.
Nastasio, Silvia; Sciveres, M; Marsalli, G; Maggiore, Giuseppe
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/776241
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact